Pharmaceutical Raw Materials Sunitinib Malate 341031-54-7
Sunitinib Malate

Usage    Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit
Usage    A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic.

Anticancer drug    Sunitinib malate is a kind of novel oral multi-targeted anticancer drugs and belongs to multi-targeted tyrosine kinase inhibitor with its trade name being "suntent". It was successfully developed by Pfizer Company and has dual anti-tumor effect. Moreover, it is the only therapeutic drug which can go beyond the 2-year survival period of advanced kidney cancer and plays a central role in the field of carcinoma and gastrointestinal stromal tumor therapeutic areas. It entered into market in February 2006 in the United States. This drug was the first anti-cancer drug which was approved by the US FDA and can simultaneously treat two diseases. 


 

Payment & Shipping Terms:

Minimum Order Quantity:25KG (25KG/Drum

Price:Negotiable

Packing:25kg/drum or as required

Delivery Time: within 24hours after receiving full payment.

Payment terms:T/T,Western Union,MoneyGram.

Supply ability:200kg/month

 

How to proceed an order: 

1st: Please let me know what you need-Which product/Cas No. quantity, and the destination country. 

2nd: You send us the purchase order once we cme to an agreement on all details. 

3rd: Parcel would be delivered upon full payment received.

4th: Express Tracking No.will be provided about the parcels.

5th: You will get the parcels in 7days.

6th: After-sales service would be provided after you receive parcels.

 

Pharmaceutical Raw Materials Sunitinib Malate 341031-54-7
Sunitinib Malate

Usage    Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit
Usage    A multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). Antineoplastic.

Anticancer drug    Sunitinib malate is a kind of novel oral multi-targeted anticancer drugs and belongs to multi-targeted tyrosine kinase inhibitor with its trade name being "suntent". It was successfully developed by Pfizer Company and has dual anti-tumor effect. Moreover, it is the only therapeutic drug which can go beyond the 2-year survival period of advanced kidney cancer and plays a central role in the field of carcinoma and gastrointestinal stromal tumor therapeutic areas. It entered into market in February 2006 in the United States. This drug was the first anti-cancer drug which was approved by the US FDA and can simultaneously treat two diseases. 


 

Payment & Shipping Terms:

Minimum Order Quantity:25KG (25KG/Drum

Price:Negotiable

Packing:25kg/drum or as required

Delivery Time: within 24hours after receiving full payment.

Payment terms:T/T,Western Union,MoneyGram.

Supply ability:200kg/month

 

How to proceed an order: 

1st: Please let me know what you need-Which product/Cas No. quantity, and the destination country. 

2nd: You send us the purchase order once we cme to an agreement on all details. 

3rd: Parcel would be delivered upon full payment received.

4th: Express Tracking No.will be provided about the parcels.

5th: You will get the parcels in 7days.

6th: After-sales service would be provided after you receive parcels.